Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of “Hold” by Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been given an average rating of “Hold” by the six brokerages that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $16.67.

MD has been the topic of a number of research analyst reports. Truist Financial cut their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 11th. Macquarie upped their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Thursday, May 8th. Finally, UBS Group lowered their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a research note on Monday, May 12th.

Pediatrix Medical Group Trading Down 2.1%

NYSE MD opened at $12.57 on Friday. The company’s 50-day moving average price is $13.83 and its 200-day moving average price is $13.86. The company has a current ratio of 1.81, a quick ratio of 1.81 and a debt-to-equity ratio of 0.75. The stock has a market cap of $1.08 billion, a PE ratio of -12.45, a PEG ratio of 0.87 and a beta of 1.25. Pediatrix Medical Group has a 12 month low of $7.40 and a 12 month high of $17.67.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.08. The firm had revenue of $458.36 million for the quarter, compared to analysts’ expectations of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The business’s revenue for the quarter was down 7.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 earnings per share. Equities research analysts forecast that Pediatrix Medical Group will post 1.38 earnings per share for the current year.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds have recently added to or reduced their stakes in MD. XTX Topco Ltd purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at about $169,000. Principal Financial Group Inc. lifted its position in shares of Pediatrix Medical Group by 6.2% during the first quarter. Principal Financial Group Inc. now owns 586,190 shares of the company’s stock valued at $8,494,000 after buying an additional 34,266 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock valued at $37,000 after buying an additional 1,765 shares during the last quarter. SG Americas Securities LLC lifted its position in shares of Pediatrix Medical Group by 194.0% during the first quarter. SG Americas Securities LLC now owns 38,405 shares of the company’s stock valued at $556,000 after buying an additional 25,343 shares during the last quarter. Finally, Deutsche Bank AG lifted its position in shares of Pediatrix Medical Group by 53.1% during the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company’s stock valued at $971,000 after buying an additional 25,663 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.